LC
ENFN

Lindbrook Capital’s Enfusion, Inc. ENFN Stock Holding History

Lindbrook Capital’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$847 Buy
+76
New +$840 ﹤0.01% 2509

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
LECM
Lead Edge Capital Management New York $408M AUM 4.05% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Lindbrook Capital's ENFN Position: Q1 2025 in Review

Lindbrook Capital opened a new position in Enfusion, Inc. (ENFN) in Q1 2025: 76 shares worth $847. The stake represents ﹤0.01% of the portfolio and ranks #2509 among its holdings.

132 funds tracked by Wall St. Rank hold ENFN as of Q1 2025.

  • Lindbrook Capital held 76 shares of Enfusion, Inc. worth $847 as of Q1 2025.
  • Enfusion, Inc. was a new Lindbrook Capital position in Q1 2025.
  • Enfusion, Inc. made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2509 holding.
  • 132 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.